Actively Recruiting
Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
Led by Sun Yat-sen University · Updated on 2024-09-19
50
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.
CONDITIONS
Official Title
Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with moderate-to-severe thyroid-associated ophthalmopathy based on EUGOGO/NOSPECS grading
- Clinical Activity Score (CAS) of 3 or less
- Stable thyroid function for at least 6 months
- Able and willing to participate in clinical trials and attend regular follow-ups
You will not qualify if you...
- Presence of uncontrollable severe mental, neurological, cardiovascular, respiratory diseases, or malignant tumors
- Other causes of eye bulging such as intraorbital tumors, inflammatory pseudotumor, or neurofibroma detected by imaging
- Eye diseases including uveitis, glaucoma, high myopia, or diabetic retinopathy
- Any other conditions that researchers consider exclusionary
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510000
Actively Recruiting
Research Team
H
Hua sheng Yang, M.D,PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here